Anaphylaxis and Epinephrine: A Strained Relationship ​
​
Over the past two decades, anaphylaxis in children, teens and adults has risen dramatically, growing by 27% from 1998 to 2008 according to the CDC. In the United States and Europe alone, estimates put the current population at risk for anaphylaxis at close to 100 million. 5 out of 6 fatal anaphylactic reactions occur outside of one's home and lack epinephrine. ​
​
In a national survey, 87% of anaphylaxis victims admitted they choose to not epinephrine simply because they are embarrassed to be carrying around the device. Because 1 in 2 anaphylaxis victims will need a second injection before medical attention arrives, it requires multiple devices to be carried at once. Devices on the market today offering more than one injection per device are difficult to use and require steps that may be difficult for a person in anaphylactic shock to complete. ​
​
Epivolve: The Solution ​
​
The days of having to compromise safety for sophistication are over. Epivolve is a sleek autoinjector that not only includes three metered doses, but a customizable outer shell that can be made specific to the user's taste. ​​
​
Our patented triple dose cartridge supplies three measured does of epinephrine in case multiple injections are necessary. Unlike other systems, the Epivolve™ requires only simple dial turn to ready a new dose. And when all three are used, the cartridge can be simply removed and refilled by your doctor. ​​
​
Epivolve™ also allows its user to create customized shells through our online website, giving users the freedom to create an Epivolve™ all their own. No longer will people feel embarrassed to carry around a bulky, plastic device. The days of carrying a bulky auto-injector are over. Epivolve™ features a lighter, smaller frame than its competition. Because it’s no bigger than a tube of lipstick, the device to be brought anywhere with little discomfort or embarrassment.